|
Index of reports
> Cases resulting in hospitalization (56)
> Cases with Anaemia (14)
Below is the selection of adverse event reports related to Retrovir (Zidovudine) that includes cases resulting in hospitalization where reactions include anaemia.
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-07-30
Patient: female, weighing 3.9 kg (8.6 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Drug Administration Error, Accidental Overdose
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir (Zidovudine)
Other drugs received by patient: Zidovudine
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-07-24
Patient: female
Adverse reactions / side effects: Anaemia, Accidental Overdose
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir (Zidovudine)
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-06-29
Patient: male, weighing 2.8 kg (6.2 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Combivir
Indication: Antiviral Prophylaxis
Start date: 2005-02-17
End date: 2005-04-06
Retrovir
Dosage: 1.1ml twice per day
Administration route: Oral
Indication: Antiviral Prophylaxis
Start date: 2005-04-06
End date: 2005-05-17
Other drugs received by patient: Retrovir; Kaletra
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-06-08
Patient: female, weighing 3.2 kg (7.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Blood Creatine Phosphokinase Increased, Flatulence, Platelet Count Increased, Blood Ketone Body Present, Hypercholesterolaemia, Malaise, Hepatomegaly, Obesity, Talipes, Hypertriglyceridaemia, Blood Pyruvic Acid Decreased, Oxygen Saturation Decreased, Supraventricular Tachycardia, Anaemia, Polyhydramnios, Tachycardia Foetal, Blood Lactic Acid Increased, Faeces Pale, Hypotonia, Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Retrovir
Administration route: Oral
Indication: Antiviral Prophylaxis
Nevirapine
Indication: Antiviral Prophylaxis
Start date: 1999-09-12
End date: 1999-09-12
Zidovudine
Indication: Antiviral Prophylaxis
Zidovudine
Indication: HIV Infection
Nevirapine
Administration route: Oral
Indication: HIV Infection
Other drugs received by patient: Ritonavir; Saquinavir; Efavirenz; Didanosine; Stavudine; Ferrostrane; Fluorex; Folic Acid; Uvesterol
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from France on 2007-05-31
Patient: female, weighing 3.2 kg (7.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Hyperlactacidaemia, Anaemia, Flatulence, Supraventricular Tachycardia, Malaise, Hepatomegaly, Obesity, Hypotonia, Neutropenia, Hypertriglyceridaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Viramune
Indication: HIV Infection
Start date: 1999-09-09
End date: 1999-09-09
Invirase
Indication: HIV Infection
Videx
Indication: Drug USE FOR Unknown Indication
Retrovir
Indication: HIV Infection
Norvir
Indication: Drug USE FOR Unknown Indication
D4T
Indication: HIV Infection
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-05-25
Patient: female, weighing 3.0 kg (6.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Blood Creatine Phosphokinase Increased, Hyperlactacidaemia, Flatulence, Mucous Stools, Platelet Count Increased, Hypercholesterolaemia, Hepatomegaly, Malaise, Obesity, Abdominal Distension, Hypertriglyceridaemia, Oxygen Saturation Decreased, Anaemia, Ventricular Tachycardia, Hypotonia, Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Videx
Dosage: received from conception to day 3 of gestation, then from week 27 of gestation to delivery
Zerit
Sustiva
Invirase
Dosage: initiated at 27 weeks of gestation
Indication: HIV Infection
Norvir
Dosage: received from week 27 of gestation to delivery
Fortovase
Dosage: received from week 27 of gestation to delivery
Viramune
Dosage: received one single oral dose, from 27 weeks gestation transplacental exposure
Administration route: Oral
Indication: HIV Infection
Viramune
Dosage: received infusion during delivery,
Retrovir
Dosage: received 6 weeks of antiretroviral therapy after delivery, 200mg/20ml
Retrovir
Dosage: received from conception to day 3 of gestation and from week 27 of gestation to and at delivery.
Other drugs received by patient: Cordarone; Speciafoldine; Ferrostrane; Uvesterol D; Fluorex; AZT
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a physician from United States on 2007-03-30
Patient: male
Adverse reactions / side effects: Anaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Efavirenz
Administration route: Oral
Start date: 2006-10-01
End date: 2007-01-01
Epivir
Administration route: Oral
Start date: 2006-10-01
End date: 2007-01-01
Retrovir
Administration route: Oral
Start date: 2006-10-01
End date: 2007-01-01
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a physician from Japan on 2007-03-05
Patient: female
Adverse reactions / side effects: Cleft LIP and Palate, Anaemia, Drug Exposure VIA Breast Milk
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Dosage: 150mg twice per day
Indication: HIV Infection
Start date: 2004-02-13
Retrovir
Indication: HIV Infection
Start date: 2004-02-13
Viracept
Indication: HIV Infection
Start date: 2004-02-13
Retrovir
Dosage: .46ml four times per day
Administration route: Oral
Start date: 2004-06-22
End date: 2004-08-03
Other drugs received by patient: Espo; Espo
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a individual with unspecified qualification from Japan on 2007-02-28
Patient: male
Adverse reactions / side effects: Anaemia, Epilepsy
Adverse event resulted in: hospitalization
Suspect drug(s):
Viramune
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-23
Nevirapine
Administration route: Oral
Start date: 2004-09-25
End date: 2004-09-25
Retrovir
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-30
Zidovudine
Start date: 2004-09-23
End date: 2004-11-18
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-30
Lamivudine
Administration route: Oral
Start date: 2004-09-28
End date: 2004-11-18
Nelfinavir Mesilate
Administration route: Oral
Start date: 2004-09-28
End date: 2004-11-18
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a individual with unspecified qualification from Japan on 2007-02-01
Patient: male
Adverse reactions / side effects: Anaemia, Epilepsy
Adverse event resulted in: hospitalization
Suspect drug(s):
Viramune
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-23
Nevirapine
Administration route: Oral
Start date: 2004-09-25
End date: 2004-09-25
Retrovir
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-30
Zidovudine
Start date: 2004-09-23
End date: 2004-11-18
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-30
Lamivudine
Administration route: Oral
Start date: 2004-09-28
End date: 2004-11-18
Nelfinavir Mesilate
Administration route: Oral
Start date: 2004-09-28
End date: 2004-11-18
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a physician from Japan on 2007-01-29
Patient: female
Adverse reactions / side effects: Cleft LIP and Palate, Anaemia, Drug Exposure VIA Breast Milk
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Dosage: 150mg twice per day
Start date: 2004-02-13
Retrovir
Start date: 2004-02-13
Viracept
Start date: 2004-02-13
Retrovir
Dosage: .46ml four times per day
Administration route: Oral
Start date: 2004-06-22
End date: 2004-08-03
Other drugs received by patient: Espo; Espo
Adverse event in 6 month old male receiving Retrovir (Zidovudine)
Reported by a physician from Japan on 2007-01-25
Patient: 6 month old male, weighing 2.5 kg (5.5 pounds)
Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Epilepsy
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Administration route: Oral
Start date: 2004-09-28
End date: 2004-11-18
Retrovir
Dosage: .38ml per day
Start date: 2004-09-23
End date: 2004-09-24
Retrovir
Administration route: Oral
Start date: 2004-09-26
End date: 2004-11-18
Retrovir
Dosage: .7ml three times per day
Administration route: Oral
Start date: 2004-10-26
End date: 2004-11-18
Epivir
Dosage: 400mg per day
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-30
Retrovir
Dosage: 300mg per day
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-30
Viramune
Start date: 2004-09-22
End date: 2004-09-23
Viracept
Administration route: Oral
Start date: 2004-09-28
End date: 2004-11-18
Viracept
Dosage: 280mg twice per day
Administration route: Oral
Start date: 2004-10-26
End date: 2004-11-18
Marijuana
Other drugs received by patient: Viramune; Bactrim; Espo; Glucose; Glucose
Adverse event in male receiving Retrovir (Zidovudine)
Reported by a individual with unspecified qualification from Japan on 2007-01-24
Patient: male
Adverse reactions / side effects: Anaemia, Epilepsy
Adverse event resulted in: hospitalization
Suspect drug(s):
Viramune
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-23
Nevirapine
Administration route: Oral
Start date: 2004-09-25
End date: 2004-09-25
Retrovir
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-30
Zidovudine
Start date: 2004-09-23
End date: 2004-11-18
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-09-22
End date: 2004-09-30
Lamivudine
Administration route: Oral
Start date: 2004-09-28
End date: 2004-11-18
Nelfinavir Mesilate
Administration route: Oral
Start date: 2004-09-28
End date: 2004-11-18
Adverse event in female receiving Retrovir (Zidovudine)
Reported by a consumer/non-health professional from United States on 2007-01-12
Patient: female
Adverse reactions / side effects: Anaemia, Thrombocythaemia, Pregnancy, Blood Lactic Acid Increased, Hypertriglyceridaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Zerit
Administration route: Oral
Start date: 1999-02-19
Viracept
Administration route: Oral
Indication: HIV Infection
Start date: 1999-02-19
Retrovir
Indication: HIV Test Positive
Start date: 1999-02-19
Epivir
Administration route: Oral
Start date: 1999-02-19
Other drugs received by patient: Methadone HCL
|
